Easterly Investment Partners’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-27,000
Closed -$215K 205
2025
Q1
$215K Sell
27,000
-18,000
-40% -$132K 0.02% 182
2024
Q4
$244K Sell
45,000
-102
-0.2% -$624 0.02% 189
2024
Q3
$326K Sell
45,102
-91,500
-67% -$838K 0.03% 188
2024
Q2
$1.48M Buy
136,602
+27,000
+25% +$346K 0.13% 129
2024
Q1
$2.05M Sell
109,602
-13,041
-11% -$301K 0.16% 118
2023
Q4
$2.66M Sell
122,643
-73,000
-37% -$1.45M 0.28% 87
2023
Q3
$4.03M Buy
195,643
+144,522
+283% +$4.17M 0.44% 76
2023
Q2
$2.4M Sell
51,121
-29,524
-37% -$1.47M 0.21% 103
2023
Q1
$3.38M Buy
80,645
+2,000
+3% +$86K 0.3% 86
2022
Q4
$3M Buy
78,645
+14,980
+24% +$572K 0.26% 91
2022
Q3
$2.49M Sell
63,665
-2,500
-4% -$96.6K 0.24% 95
2022
Q2
$2.14M Buy
66,165
+32,555
+97% +$1.09M 0.19% 102
2022
Q1
$1.11M Buy
+33,610
New +$1.26M 0.08% 136

Other funds holding SAGE